CHD4 and neoplasm: Together, these findings show that FBXW7 physically interacts with CHD4 and mediates its ubiquitination, which highlights that targeting CHD4 may be a promising therapeutic strategy for eradicating BCSCs to overcome tumor relapse, metastasis and drug resistance in TNBC.